Prevalence and cost of epilepsy in Sweden - a register-based approach
- 7 September 2014
- journal article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 131 (1) , 37-44
Abstract
To estimate the prevalence of epilepsy, costs associated with in- and outpatient care, drug utilization and productivity losses due to epilepsy in Sweden for the years 2005 and 2011. Cost components were calculated using registry data on inpatient- and outpatient-care utilization, drug sales and early pensions granted due to permanent disability and mortality. Moreover, by cross-identification of information in healthcare and pharmaceutical registries, we were able to distinguish between pharmaceuticals prescribed for epilepsy and non-epilepsy indications. The prevalence of epilepsy was estimated at 0.62% in 2005 and 0.88% in 2011. The total cost of epilepsy increased during the same period, while the per-patient cost decreased from €2929 to €1729. Direct medical costs accounted for about 36% of the estimated total cost in 2005 and 60% in 2011. The estimated healthcare cost due to epilepsy as a share of total healthcare costs for all illnesses was about the same in 2005 as in 2011 (0.2%), while the corresponding pharmaceutical cost increased from about 0.5% in 2005 to almost 1% in 2011. The per-patient cost of epilepsy is substantial, implying a significant aggregated cost incurred on society (despite a prevalence < 1%). Our results suggest that the per-patient pharmaceutical utilization increased, while the per-patient physician visits and hospitalizations decreased, between 2005 and 2011. Moreover, we demonstrate that the 2005 prevalence measure was underestimated the true prevalence in 2005.Keywords
Funding Information
- UCB Nordic
This publication has 19 references indexed in Scilit:
- Retigabine as add-on treatment of refractory epilepsy - a cost-utility study in a Swedish settingActa Neurologica Scandinavica, 2013
- Cause‐specific mortality among patients with epilepsy: Results from a 30‐year cohort studyEpilepsia, 2012
- Epilepsy in Sweden: health care costs and loss of productivity—a register-based approachThe European Journal of Health Economics, 2011
- Lacosamide as treatment of epileptic seizures - cost utility results for SwedenActa Neurologica Scandinavica, 2010
- The descriptive epidemiology of epilepsy—A reviewEpilepsy Research, 2009
- Epilepsy in an Italian community as assessed by a survey for prescriptions of antiepileptic drugs: epidemiology and patterns of careActa Neurologica Scandinavica, 2009
- Cost of EpilepsyPharmacoEconomics, 2008
- Health related quality of life in adult patients with epilepsy compared with a general reference population in TaiwanEpilepsy Research, 2005
- Prevalence of Epilepsy in Adults in Northern SwedenEpilepsia, 1992
- Economic costs of epilepsy - treatment benefitsActa Neurologica Scandinavica, 1988